Hormonal systems also interact with medication tolerance in ways that are often overlooked
173(9):694703 Veerman JL, Barendregt JJ, Forster M, Vos T (2011) Cost-effectiveness of pharmacotherapy to reduce obesity
While not first-line therapies, both drug classes show promise as adjuncts in high-risk populations
P = 0.32) 28 and leptin (1.67 [2.64, 0.70]
To understand who is actually a candidate and what monitoring looks like, see our expert review of whether peptides are safe for weight loss, including who is a candidate, what monitoring matters, and the right questions to ask a licensed provider
As a GIP/GLP-1 receptor agonist, tirzepatide enhances glucose-dependent insulin secretion from pancreatic beta cells, suppresses inappropriately elevated glucagon secretion, and slows gastric emptying